Overexpression of SCN5A overcomes ABC transporter-mediated multidrug resistance in acute myeloid leukemia through promoting apoptosis

References

• Pelcovits A, Niroula R. Acute myeloid leukemia: a review. R I Med J (2013). 2020;103(3):38–40.
   PubMedGoogle Scholar
• Zeng YJ, Wu M, Zhang H, et al. Effects of Qinghuang powder on acute myeloid leukemia based on network pharmacology, molecular docking, and in vitro experiments. Evid Based Complement Alternat Med. 2021;2021(6195174):1–14. doi: 10.1155/2021/6195174
   Google Scholar
• Xuan L, Liu Q. Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation. J Hematol Oncol. 2021 Jan 6;14(1):4. doi: 10.1186/s13045-020-01017-7
   PubMed Web of Science ®Google Scholar
• Pollyea DA, Altman JK, Assi R, et al. Acute myeloid leukemia, version 3.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2023;21(5):503–513. doi: 10.6004/jnccn.2023.0025
   PubMed Web of Science ®Google Scholar
• Estey EH. Acute myeloid leukemia: 2019 update on risk-stratification and management. Am J Hematol. 2018;93(10):1267–1291. doi: 10.1002/ajh.25214
   PubMed Web of Science ®Google Scholar
• Ganesan S, Mathews V, Vyas N. Microenvironment and drug resistance in acute myeloid leukemia: do we know enough? Int J Cancer. 2022;150(9):1401–1411. doi: 10.1002/ijc.33908
   PubMed Web of Science ®Google Scholar
• Short NJ, Rytting ME, Cortes JE. Acute myeloid leukaemia. Lancet. 2018;392(10147):593–606. doi: 10.1016/S0140-6736(18)31041-9
   PubMed Web of Science ®Google Scholar
• Catterall WA. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron. 2000;26(1):13–25. doi: 10.1016/S0896-6273(00)81133-2
   PubMed Web of Science ®Google Scholar
• Catterall WA. Voltage-gated sodium channels at 60: structure, function and pathophysiology. J Physiol. 2012;590(11):2577–2589. doi: 10.1113/jphysiol.2011.224204
   PubMed Web of Science ®Google Scholar
• Patel F, Brackenbury WJ. Dual roles of voltage-gated sodium channels in development and cancer. Int J Dev Biol. 2015;59(7–8–9):357–366. doi: 10.1387/ijdb.150171wb
   PubMed Web of Science ®Google Scholar
• Martin F, Ufodiama C, Watt I, et al. Therapeutic value of voltage-gated sodium channel inhibitors in breast, colorectal, and prostate cancer: a systematic review. Front Pharmacol. 2015;6(273). doi: 10.3389/fphar.2015.00273
   Google Scholar
• Besson P, Driffort V, Bon E, et al. How do voltage-gated sodium channels enhance migration and invasiveness in cancer cells? Biochim Biophys Acta. 2015;1848(10 Pt B):2493–2501. doi: 10.1016/j.bbamem.2015.04.013
   PubMed Web of Science ®Google Scholar
• Liu M, Yang KC, Dudley SC Jr. Cardiac sodium channel mutations: why so many phenotypes? Curr Top Membr. 2016;78:513–559.
   PubMed Web of Science ®Google Scholar
• Zhang J, Mao W, Dai Y, et al. Voltage-gated sodium channel Nav1.5 promotes proliferation, migration and invasion of oral squamous cell carcinoma. Acta Biochim Biophys Sin. 2019;51(6):562–570. doi: 10.1093/abbs/gmz044
   Google Scholar
• Liu C, Yu M, Li Y, et al. Lidocaine inhibits the metastatic potential of ovarian cancer by blocking Na(V) 1.5-mediated EMT and FAK/Paxillin signaling pathway. Cancer Med. 2021;10(1):337–349. doi: 10.1002/cam4.3621
   PubMed Web of Science ®Google Scholar
• Luo Q, Wu T, Wu W, et al. The functional role of voltage-gated sodium channel Nav1.5 in metastatic breast cancer. Front Pharmacol. 2020;11:1111. doi: 10.3389/fphar.2020.01111
   PubMed Web of Science ®Google Scholar
• Lastraioli E, Fraser SP, Guzel RM, et al. Neonatal Nav1.5 protein expression in human colorectal cancer: immunohistochemical characterization and clinical evaluation. Cancers. 2021;13(15):3832. doi: 10.3390/cancers13153832
   PubMed Web of Science ®Google Scholar
• Sui Q, Peng J, Han K, et al. Voltage-gated sodium channel Na(v)1.5 promotes tumor progression and enhances chemosensitivity to 5-fluorouracil in colorectal cancer. Cancer Lett. 2021;500:119–131. doi: 10.1016/j.canlet.2020.12.017
   PubMed Web of Science ®Google Scholar
• Briot T, Roger E, Thepot S, et al. Advances in treatment formulations for acute myeloid leukemia. Drug Discov Today. 2018;23(12):1936–1949. doi: 10.1016/j.drudis.2018.05.040
   PubMed Web of Science ®Google Scholar
• Ma H, Cheng L, Hao K, et al. Reversal effect of ST6GAL 1 on multidrug resistance in human leukemia by regulating the PI3K/Akt pathway and the expression of P-gp and MRP1. PLoS One. 2014;9(1):e85113. doi: 10.1371/journal.pone.0085113
   PubMed Web of Science ®Google Scholar
• Turk S, Turk C, Akbar MW, et al. Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with doxorubicin as well as etoposide. PLoS One. 2020;15(11):e0242497. doi: 10.1371/journal.pone.0242497
   PubMed Web of Science ®Google Scholar
• Gao R, Shen Y, Cai J, et al. Expression of voltage-gated sodium channel alpha subunit in human ovarian cancer. Oncol Rep. 2010;23(5):1293–1299. doi: 10.3892/or_00000763
   PubMed Web of Science ®Google Scholar
• House CD, Vaske CJ, Schwartz AM, et al. Voltage-gated Na+ channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion. Cancer Res. 2010;70(17):6957–6967. doi: 10.1158/0008-5472.CAN-10-1169
   PubMed Web of Science ®Google Scholar
• Amawi H, Sim HM, Tiwari AK, et al. ABC transporter-mediated multidrug-resistant cancer. Adv Exp Med Biol. 2019;1141:549–580.
   PubMed Web of Science ®Google Scholar
• Li W, Zhang H, Assaraf YG, et al. Overcoming ABC transporter-mediated multidrug resistance: molecular mechanisms and novel therapeutic drug strategies. Drug Resist Updat. 2016;27:14–29. doi: 10.1016/j.drup.2016.05.001
   PubMed Web of Science ®Google Scholar
• Robey RW, Pluchino KM, Hall MD, et al. Revisiting the role of ABC transporters in multidrug-resistant cancer. Nat Rev Cancer. 2018;18(7):452–464. doi: 10.1038/s41568-018-0005-8
   PubMed Web of Science ®Google Scholar
• Safar Z, Kis E, Erdo F, et al. ABCG2/BCRP: variants, transporter interaction profile of substrates and inhibitors. Expert Opin Drug Metab Toxicol. 2019;15(4):313–328. doi: 10.1080/17425255.2019.1591373
   PubMed Web of Science ®Google Scholar
• Dive C. Avoidance of apoptosis as a mechanism of drug resistance. J Intern Med Suppl. 1997;740(S740):139–145. doi: 10.1111/joim.1997.242.s740.139
   PubMedGoogle Scholar
• Wang Z, Yu K, Hu Y, et al. Schisantherin a induces cell apoptosis through ROS/JNK signaling pathway in human gastric cancer cells. Biochem Pharmacol. 2020;173(113673):113673. doi: 10.1016/j.bcp.2019.113673
   PubMedGoogle Scholar
• Lee SY, Peckermann I, Abinet E, et al. The rare-earth yttrium complex [Yr(mtbmp)(thf)] triggers apoptosis via the extrinsic pathway and overcomes multiple drug resistance in leukemic cells. Med Oncol. 2012;29(1):235–242. doi: 10.1007/s12032-010-9787-6
   PubMed Web of Science ®Google Scholar
• Kater L, Kater B, Jakupec MA, et al. KP772 overcomes multiple drug resistance in malignant lymphoma and leukemia cells in vitro by inducing bcl-2-independent apoptosis and upregulation of Harakiri. J Biol Inorg Chem. 2021;26(8):897–907. doi: 10.1007/s00775-021-01900-9
   PubMed Web of Science ®Google Scholar